Multidrug resistant tuberculosis – can the tide be turned?

Despite the global increase in tuberculosis and the worrying rise in the number of cases resistant to the two principal antituberculosis drugs, isoniazid and rifampicin, the authors of a personal view in the current issue of the Lancet Infectious Diseases think that if action is taken now this tide can be turned (1).